MedPath

A post market clinical follow up study of Sterile Hydroxy Propyl Methyl Cellulose Eye Drops

Phase 4
Completed
Conditions
Health Condition 1: H579- Unspecified disorder of eye and adnexa
Registration Number
CTRI/2024/02/062930
Lead Sponsor
Amanta Healthcare Limited
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
65
Inclusion Criteria

Subjects who are able to give voluntary, written informed consent to participate in this study.

Subjects who experience as eye dryness, eye soreness/ burning, irritative sensation, eye fatigue, contact lens caused dryness, discomfort of eyes due to the continuous use of computer/ TV/ exposed pollution/ dry environment.

Exclusion Criteria

Anyone with known allergic reaction to Sterile Hydroxy Propyl Methyl Cellulose Eye Drops.

Subjects with existing eye infection.

History of ocular surgery. History or active signs of severe or serious ocular conditions such as inflammatory corneal ulcers, recurrent erosions, and uveitis at any time

Patients participating in any another clinical trial during study

Pregnant/lactating women during study period.

Study & Design

Study Type
PMS
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary objective will be, to confirm clinical safety and performance of the product Sterile Hydroxy Propyl Methyl Cellulose Eye Drops from the baseline with follow up visits. <br/ ><br>Timepoint: 1st Visit - After 8 days of using the product <br/ ><br>2nd Visit - After one month of using the product <br/ ><br>3rd Visit - After two months of using the product <br/ ><br>4th Visit - After three months of using the product <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
The secondary objective will be to assess clinical benefits, contraindications and possible misuse/ off-label use during the use of the product. Also, the continued acceptability of benefit-risk ratio will be ensured during the study. Overall subject and PI satisfaction will be recorded in the case report form.Timepoint: 1st Visit - After 8 days of using the product <br/ ><br>2nd Visit - After one month of using the product <br/ ><br>3rd Visit - After two months of using the product <br/ ><br>4th Visit - After three months of using the product
© Copyright 2025. All Rights Reserved by MedPath